Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunfeng Fu

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Oncotargets and Therapy|April 29, 2021
Expression Profiles of tRNA-Derived Fragments and Their Potential Roles in Multiple MyelomaCong Xu, Yunfeng Fu
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|December 19, 2024
[Construction of a prediction model of ultrasound indicators for mortality risk within 7 days in patients with acute myocardial infarction and ventricular septal rupture]Yunfeng Fu, Zhongshu Liang, Wenchang Feng
Current Treatment Options in Oncology|October 21, 2024
Acquired Bortezomib Resistance in Multiple Myeloma: From Mechanisms to StrategyFangfang Li, Jing Liu, Yunfeng Fu
Scientific Reports|May 26, 2023
IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myelomaCong Xu, Meng Gao, Junhua Zhang, et al.
Biomed Research International|September 23, 2014
Destabilization of akt promotes the death of myeloma cell linesYanan Zhang, Yunfeng Fu, Fan Zhang, et al.
Oncotargets and Therapy|February 6, 2020
PHLPP Sensitizes Multiple Myeloma Cells to Bortezomib Through Regulating LAMP2Xiao Liu, Chengyuan Li, Yunfeng Fu, et al.
Frontiers in Pharmacology|August 1, 2022
RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell LymphomaCong Xu, Ting Liang, Jing Liu, et al.
Cancer Management and Research|March 27, 2020
hsa_circRNA_012515 Is Highly Expressed in NSCLC Patients and Affects Its PrognosisYunfeng Fu, Liang Huang, Hao Tang, et al.
Frontiers of Medicine|December 28, 2013
Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 casesYunfeng Fu, Xinyu Wang, Zimin Pan, et al.
Bioengineered|February 10, 2022
MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3HongXia Chen, YunFeng Fu, ZiXiang Guo, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Oncotargets and Therapy|April 29, 2021
Expression Profiles of tRNA-Derived Fragments and Their Potential Roles in Multiple MyelomaCong Xu, Yunfeng Fu
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|December 19, 2024
[Construction of a prediction model of ultrasound indicators for mortality risk within 7 days in patients with acute myocardial infarction and ventricular septal rupture]Yunfeng Fu, Zhongshu Liang, Wenchang Feng
Current Treatment Options in Oncology|October 21, 2024
Acquired Bortezomib Resistance in Multiple Myeloma: From Mechanisms to StrategyFangfang Li, Jing Liu, Yunfeng Fu
Scientific Reports|May 26, 2023
IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myelomaCong Xu, Meng Gao, Junhua Zhang, et al.
Biomed Research International|September 23, 2014
Destabilization of akt promotes the death of myeloma cell linesYanan Zhang, Yunfeng Fu, Fan Zhang, et al.
Oncotargets and Therapy|February 6, 2020
PHLPP Sensitizes Multiple Myeloma Cells to Bortezomib Through Regulating LAMP2Xiao Liu, Chengyuan Li, Yunfeng Fu, et al.
Frontiers in Pharmacology|August 1, 2022
RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell LymphomaCong Xu, Ting Liang, Jing Liu, et al.
Cancer Management and Research|March 27, 2020
hsa_circRNA_012515 Is Highly Expressed in NSCLC Patients and Affects Its PrognosisYunfeng Fu, Liang Huang, Hao Tang, et al.
Frontiers of Medicine|December 28, 2013
Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 casesYunfeng Fu, Xinyu Wang, Zimin Pan, et al.
Bioengineered|February 10, 2022
MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3HongXia Chen, YunFeng Fu, ZiXiang Guo, et al.
Pageof 9